LITSLite Strategy

Crypto · Financial Services · Nasdaq

Lite Strategy, Inc. (Nasdaq: LITS) is a pharmaceutical company that has historically developed novel and differentiated cancer therapies. 10-K, Item 1

Headquarters: San Diego, CA
CEO: Justin J. File
Next results: around Feb 16, 2027

Compare with peers → Embed

Key numbers

Latest fiscal year, with ten years behind each

RevenueFY2017–26 $0 FY2025: $0 10-K FY2026 · XBRL Net incomeFY2017–26 −$71.2M FY2025: −$15.9M 10-K FY2026 · XBRL

What changed

10-K filed Sep 28, 2026 against Sep 26, 2025

Area	What changed	Source
Risk factors	4 new paragraphs, nothing like them in the previous 10-K	10-K Item 1A
Auditor change	8-K item 4.01 (change in certifying accountant) filed 2025-12-05	10-K · XBRL
Accounting checks	6 other checks clear, 1 worth a look	10-K · XBRL
Insiders	No open-market buys in the last 90 days	Form 4
Filings	3 in the last 30 days	EDGAR

Each row opens the detail with the quote and the filing. A row is a change worth reading, not a verdict.

What's new, in their words

10-K filed Sep 28, 2026

Paragraphs in Risk Factors that were not in the 10-K filed 2025-09-26. Quoted as filed.

We intend to monitor our assets and income in order to conduct our business activities in a manner such that we do not fall within the definition of “investment company” under the 1940 Act or would qualify under one of the exemptions or exclusions
10-K, Item 1A

All 4 new paragraphs →

Accounting checks

latest 10-K

6 of 7 clear 1 worth a look. Checks, not verdicts.

!
Auditor change8-K item 4.01 (change in certifying accountant) filed 2025-12-05
✓
No statement of substantial doubt about going concern
✓
No 8-K item 4.02 in the last 2 years
✓
No NT 10-K or NT 10-Q in the last 2 years
✓
No sentence in the 10-K concludes that controls were not effective because of a material weakness
✓
No 8-K item 2.06 in the last 2 years
✓
No 8-K item 1.03 in the last 2 years

How each check works, with sources →

In the last 30 days

All filings →

Nov 5, 202610-Q Quarterly report (10-Q) period ended Sep 30, 2026
Nov 3, 20268-K Unregistered share sale 8-K item 3.02
Oct 26, 2026Buy Glover Nicholas (Director) bought $13K open-market purchase on Jul 22, 2025, reported 1 year late

Get an email when this changes: new risk paragraphs, accounting items, insider purchases, a new 10-K or 10-Q. RSS feed

Work on LITS in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/LITS/export.csv") into a cell.